|Bid||218.02 x 800|
|Ask||218.02 x 800|
|Day's Range||217.48 - 220.71|
|52 Week Range||144.75 - 223.45|
|Beta (3Y Monthly)||1.01|
|PE Ratio (TTM)||23.34|
|Earnings Date||Oct 23, 2019 - Oct 28, 2019|
|Forward Dividend & Yield||2.08 (0.95%)|
|1y Target Est||227.31|
In the near future, there is a probability of 3D-printed implantable organs becoming a reality, thereby increasing the number of lives saved.
We highlight ETFs which are set to gain from an expanding surgical robotic market on factors like growing demand for automation in healthcare, rising cases of chronic diseases and ageing population.
Stryker (SYK) announced today a definitive agreement to acquire Mobius Imaging, LLC, a leader in point-of-care imaging technology, and its sister company, GYS Tech, LLC (DBA Cardan Robotics), in an all cash transaction of approximately $370 million upfront and up to $130 million of contingent payments associated with development and commercial milestones. The acquisition provides Stryker’s Spine division with immediate entry into the intra-operative imaging segment and aligns with Stryker’s implant and navigation offerings.
The robots are coming. Don't be afraid. These machines are changing medicine for the better -- one hip and knee replacement at a time, asserts growth stock expert Jon Markman, editor of Pivotal Point.
So far, the levies and prospect of additional tariffs have not cooled investors’ enthusiasm for the shares of industry members Continue reading...
Stryker, Varian Medical Systems and Becton, Dickinson & Co. could feel pressure after China targeted medical products in another round of tariffs on imports, an analyst said Thursday.
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 8:35 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. The webcast will be archived on the Investor Relations page of this site.
President and COO of Stryker Corp (30-Year Financial, Insider Trades) Timothy J Scannell (insider trades) sold 4,666 shares of SYK on 08/16/2019 at an average price of $217.08 a share. Continue reading...
Spencer S. Stiles will serve as Group President of Orthopaedics and Spine and will oversee Stryker’s Joint Replacement, Trauma & Extremities and Spine divisions. J. Andrew Pierce, Group President of MedSurg and Neurotechnology will oversee Stryker’s Instruments, Medical, Endoscopy, Sustainability and Neurotechnology businesses.